Scientific work

Prof. Dr. İbrahim Yıldız

113 publications. The source of the information is stated next to each publication.

Back to profile

  1. Real-world effectiveness of total neoadjuvant therapy in locally advanced rectal cancer: a multicenter retrospective study

    Discover Oncology, 2026

    DOI 10.1007/s12672-026-04842-3 PMID 41870760 Open-access full textSource: OpenAlex

  2. Comparison of First-Line Pembrolizumab Monotherapy Versus Chemo-Immunotherapy in Metastatic Non-Small Cell Lung Cancer Patients with PD-L1 TPS ≥ 50%: A Multicenter Real-World Study from Turkey

    Medicina, 2026

    DOI 10.3390/medicina62112136 Open-access full textSource: OpenAlex

  3. Effect of Primary Breast Surgery on Prognosis in Breast Cancer Patients Presenting with Isolated Bone Metastases

    Cancers, 2026

    DOI 10.3390/cancers18111760 PMID 42279343 Open-access full textSource: OpenAlex

  4. Clinicopathological Characteristics and Survival Outcomes of Male Breast Lymphoma

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15187136 PMID 42795909 Open-access full textSource: OpenAlex

  5. The effect of perioperative radiotherapy on prognosis in patients with operable rectal cancer who received neoadjuvant chemotherapy and underwent surgery.

    Journal of Clinical Oncology, 2026

    DOI 10.1200/jco.2026.44.16_suppl.e15681 Source: OpenAlex

  6. Abstract PS4-08-16: Evaluation of Clinicopathological Features and Prognoses of Male Patients with Breast Lymphoma

    Clinical Cancer Research, 2026

    DOI 10.1158/1557-3265.sabcs25-ps4-08-16 Source: OpenAlex

  7. Abstract PS1-09-11: Comparison of Clinicopathological Features and Prognoses in Male and Female Patients with Denovo Metastatic Breast Cancer

    Clinical Cancer Research, 2026

    DOI 10.1158/1557-3265.sabcs25-ps1-09-11 Source: OpenAlex

  8. Abstract PS1-09-10: Effect of Primary Breast Surgery on Prognosis in Breast Cancer Patients with Isolated Bone Metastases

    Clinical Cancer Research, 2026

    DOI 10.1158/1557-3265.sabcs25-ps1-09-10 Source: OpenAlex

  9. Abstract PS4-08-17: Evaluation of Clinicopathological Features and Prognoses of Female Breast Sarcoma Patients

    Clinical Cancer Research, 2026

    DOI 10.1158/1557-3265.sabcs25-ps4-08-17 Source: OpenAlex

  10. HPV-positive oropharyngeal squamous cell carcinoma: risk-adapted treatment strategies and biomarker-guided individualization

    Oral Oncology, 2026

    DOI 10.1016/j.oraloncology.2026.108005 PMID 42107222 Source: OpenAlex

  11. Risk-adaptive management of stage III NSCLC in the perioperative immunotherapy era: a critical synthesis and clinical framework

    Frontiers in Oncology, 2026

    DOI 10.3389/fonc.2026.1897546 PMID 42775057 Open-access full textSource: OpenAlex

  12. Evolving Concepts and Contemporary Management of Early-Stage Breast Cancer: An Evidence-Based Approach to Grey Zones from a Comprehensive Breast Unit Part 2: Systemic Treatment

    European Journal of Breast Health, 2025

    DOI 10.4274/ejbh.galenos.2025.2025-10-2 PMID 41447641 Open-access full textSource: OpenAlex

  13. Next-generation sequencing-based genomic profiling of advanced soft tissue and bone sarcomas

    Frontiers in Oncology, 2025

    DOI 10.3389/fonc.2025.1627452 PMID 41114372 5 citations (Europe PMC) Open-access full textSource: OpenAlex

  14. 115P Changes in surgical and oncological characteristics of early-onset and late-onset colorectal cancers over five-year periods: A single-center 10-year experience

    Annals of Oncology, 2025

    DOI 10.1016/j.annonc.2025.05.127 Source: OpenAlex

  15. Efficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study

    Expert Opinion on Pharmacotherapy, 2024

    DOI 10.1080/14656566.2024.2337261 PMID 38568074 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  16. Total Neoadjuvant Therapy Versus Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: A Multi-Institutional Real-World Study

    Cancers, 2024

    DOI 10.3390/cancers16183213 PMID 39335184 8 citations (Europe PMC) Open-access full textSource: OpenAlex

  17. Current trends in perioperative treatment of resectable gastric cancer

    World Journal of Gastrointestinal Surgery, 2023

    DOI 10.4240/wjgs.v15.i3.323 PMID 37032791 5 citations (Europe PMC) Open-access full textSource: OpenAlex

  18. The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey

    Medicine, 2023

    DOI 10.1097/md.0000000000035950 PMID 37960746 7 citations (Europe PMC) Open-access full textSource: OpenAlex

  19. Discrepancy among microsatellite instability detection methodologies in non-colorectal cancer: Report of 3 cases

    World Journal of Clinical Cases, 2023

    DOI 10.12998/wjcc.v11.i13.3105 PMID 37215411 Open-access full textSource: OpenAlex

  20. Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1–2 cm

    The Lancet Oncology, 2023

    DOI 10.1016/s1470-2045(23)00098-0 PMID 37142376 3 citations (Europe PMC) Source: OpenAlex

  21. Intramural Component of Venous, Lymphatic, and Perineural Invasion in Colon Cancer: A Threat or an Illusion?

    Balkan Medical Journal, 2022

    DOI 10.4274/balkanmedj.galenos.2022.2022-6-94 PMID 36317726 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  22. The professional seniority affects the clinical application of total neoadjuvant therapy for locally advanced rectal cancer.

    Journal of Clinical Oncology, 2022

    DOI 10.1200/jco.2022.40.16_suppl.e15590 Source: OpenAlex

  23. The prognostic impact of intramural invasion in patients undergoing surgery for non-metastatic colon cancer.

    Journal of Clinical Oncology, 2022

    DOI 10.1200/jco.2022.40.16_suppl.e15516 Source: OpenAlex

  24. P84.03 GLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients

    Journal of Thoracic Oncology, 2021

    DOI 10.1016/j.jtho.2021.01.1202 Open-access full textSource: OpenAlex

  25. Tailored total neoadjuvant therapy for locally advanced rectal cancer: One size may not fit for all!

    Colorectal Disease, 2021

    DOI 10.1111/codi.15669 PMID 33829626 8 citations (Europe PMC) Source: OpenAlex

  26. GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients

    Lung Cancer, 2020

    DOI 10.1016/j.lungcan.2020.07.022 PMID 32799090 30 citations (Europe PMC) Source: OpenAlex

  27. Clinicopathological and prognostic significance of microsatellit instability (MSI) status and PDl-1 expression in Turkish patients with gastric cancer.

    Journal of Clinical Oncology, 2019

    DOI 10.1200/jco.2019.37.15_suppl.e15538 1 citation (OpenAlex) Source: OpenAlex

  28. P1.14-15 Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey

    Journal of Thoracic Oncology, 2019

    DOI 10.1016/j.jtho.2019.08.1166 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  29. Adjuvant Systemic Therapy: Endocrine Therapy

    Springer eBooks, 2019

    DOI 10.1007/978-3-030-16792-9_7 Source: OpenAlex

  30. Adjuvant Endocrine Therapy for Breast Cancer

    Springer eBooks, 2018

    DOI 10.1007/978-3-319-96947-3_17 Source: OpenAlex

  31. The role of FOLFOXIRI in chemorefractory metastatic colorectal cancer patients

    Journal of Oncological Sciences, 2018

    DOI 10.1016/j.jons.2018.03.001 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  32. P3.01-33 EGFR Mutation in Patients with NSCLC and Its Relationship Between Survival and Clinicopathological Features: An Update Analysis

    Journal of Thoracic Oncology, 2018

    DOI 10.1016/j.jtho.2018.08.1593 Open-access full textSource: OpenAlex

  33. Prognostic factors for survival in metastatic renal cell carcinoma patients with brain metastases receiving targeted therapy

    Tumori Journal, 2017

    DOI 10.5301/tj.5000635 PMID 28731496 7 citations (Europe PMC) Source: OpenAlex

  34. Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study

    Cancer Investigation, 2017

    DOI 10.1080/07357907.2017.1292518 PMID 28333566 6 citations (Europe PMC) Source: OpenAlex

  35. Prognostic value of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with epithelial ovarian cancer.

    PubMed, 2017

    PMID 29693888 5 citations (Europe PMC) Source: OpenAlex

  36. SERUM LEVELS OF OMENTIN-1 IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER: THE IZMIR ONCOLOGY GROUP (IZOG) STUDY

    2017

    DOI 10.19193/0393-6384_2017_4_080 4 citations (OpenAlex) Source: OpenAlex

  37. Prognostic relevance of sunitinib toxicities and comparison of continuous vs. intermittent sunitinib dosing schedule in metastatic renal cell cancer patients

    Współczesna Onkologia, 2016

    DOI 10.5114/wo.2016.60069 PMID 27358594 Open-access full textSource: OpenAlex

  38. Current adjuvant treatment modalities for gastric cancer: From history to the future

    World Journal of Gastrointestinal Oncology, 2016

    DOI 10.4251/wjgo.v8.i5.439 PMID 27190583 16 citations (Europe PMC) Open-access full textSource: OpenAlex

  39. Adjuvant Systemic Therapy: Endocrine Therapy

    Springer eBooks, 2016

    DOI 10.1007/978-3-319-26012-9_7 Source: OpenAlex

  40. Sexual satisfaction, anxiety, depression and quality of life amoung Turkish gynecological cancer patients

    Annals of Oncology, 2016

    DOI 10.1093/annonc/mdw374.38 5 citations (OpenAlex) Open-access full textSource: OpenAlex

  41. Thrombin activatable fibrinolysis inhibitor, tissue factor pathway inhibitor, and prothrombin fragment 1+2 levels in patients with advanced colorectal cancer.

    Journal of Clinical Oncology, 2016

    DOI 10.1200/jco.2016.34.4_suppl.615 Source: OpenAlex

  42. Evaluation of c-kit (CD 117) expression as a prognostic factor in testicular germ cell tumors: An Izmir Oncology Group (IZOG) study.

    Journal of Clinical Oncology, 2016

    DOI 10.1200/jco.2016.34.2_suppl.476 Source: OpenAlex

  43. Clinical significance of serum protease-activated receptor 1 (PAR1) level in patients with breast cancer

    Journal of Oncological Sciences, 2016

    DOI 10.1016/j.jons.2016.04.003 Source: OpenAlex

  44. Alteration of thyroid functions in patients with renal cell carcinoma treated with tyrosine kinase inhibitors; Turkish population study.

    DergiPark (Istanbul University), 2016

    Source: OpenAlex

  45. Sexual satisfaction, anxiety, depression and quality of life among Turkish colorectal cancer patients [Izmir Oncology Group (IZOG) study]

    Japanese Journal of Clinical Oncology, 2015

    DOI 10.1093/jjco/hyv051 PMID 25862825 26 citations (Europe PMC) Source: OpenAlex

  46. D-dimer and international normalized ratio (INR) are correlated with tumor markers and disease stage in colorectal cancer patients

    Cancer Biomarkers, 2015

    DOI 10.3233/cbm-150477 PMID 25792472 24 citations (Europe PMC) Open-access full textSource: OpenAlex

  47. Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancers

    Biomedicine & Pharmacotherapy, 2015

    DOI 10.1016/j.biopha.2015.01.019 PMID 25776500 19 citations (Europe PMC) Source: OpenAlex

  48. The Effects of Adjuvant Endocrine Treatment on Serum Leptin, Serum Adiponectin and Body Composition in Patients with Breast Cancer: The Izmir Oncology Group (IZOG) Study

    Chemotherapy, 2015

    DOI 10.1159/000440944 PMID 26571369 15 citations (Europe PMC) Source: OpenAlex

  49. Adjuvant Chemotherapy and Prognostic Factors in Stage II Colon Cancer - Izmir Oncology Group Study

    Asian Pacific Journal of Cancer Prevention, 2015

    DOI 10.7314/apjcp.2015.16.6.2413 PMID 25824774 8 citations (Europe PMC) Open-access full textSource: OpenAlex

  50. Uracil/tegafur as a possible salvage therapy in chemo-refractory colorectal cancer patients: a single institutional retrospective study

    Współczesna Onkologia, 2015

    DOI 10.5114/wo.2015.53374 PMID 26793023 2 citations (Europe PMC) Open-access full textSource: OpenAlex